Page 23 - BOL Mar 22 Edition

your one-stop shop for...

fruit & vegetables organic cafe
grocery & bulk food We oer delicious food & drinks all made
gluten free products using quality certied organic ingredients.
meat, eggs & dairy

vegan & vegetarian products Wheat free, gluten free & dairy free
options available.
cleaning & personal care products

SKIN CANCER -WHAT IS IT?
The Latest
NON NEGOTIABLES
Skin cancer is an abnormal growth of a cell type in
the skin. The most common type is Basal Cell cancer
(BCC), a slow growing and locally destructive cancer.
when microneedling have arrived...
Squamous Cell Cancer (SCC) is a more invasive cancer.
Melanomas can grow quickly and can become life-
threatening in as little as six weeks. Less commonly
Introducing Dp Dermaceuticals MG-Collection
known is that Melanoma can appear on skin not
The Ultimate Innovation for Professional Microneedling
normally exposed to the sun.
Treatment of Skin Cancer
Potent HylaFuse™ Complex
Surgical excision of the cancer is the present
Calphasomes™ Ageing & Scars
such as prescribed cream and cryotherapy, (otherwise
Telomeres
forms of BCC and SCC but will require ongoing reviews
to ensure no return.
Bioactives
Acne
Precancerous skin cancer or solar keratosis (otherwise
referred to as the sunspot) is treated with cryotherapy
or topical cream such as prescription Efudix to ensure
it does not become a SCC.
Detection of Skin Cancer
With no formal screening program in Australia, it
is important to have a thorough skin examination
with your GP on a regular basis. Doctor Donna at
Bartchall Medical specialises in skin cancer checks
Pigmentation
and management and the staff at the clinic send out
timely reminders to have your skin cancer check done
regularly, so you never have to worry about forgetting!
Make your appointment for a Skin Cancer Check
The ultimate at Bartchall Medical today!
convenience
perfectly blended
sterile
luer-lock nozzle
single use
March 2022 www.bestoflocal.com.au 23
23/09/2020 1:12:47 PM
23/09/2020 1:12:47 PM
BM_Oct20_Opt2.indd 1
BM_Oct20_Opt2.indd 1